Prostate cancer decisions — 2023

The Board has decided to remand the case due to insufficient medical opinions regarding whether prostate cancer is related to service or any event, injury, or disease in service, including asbestos and lead paint exposure. The Veteran's claim will be further developed for a VA examination.

The Veteran's atherosclerotic heart disease and prostate cancer residuals are granted as service-connected due to herbicide exposure in Thailand. The PACT Act does not apply, but the Board finds credible evidence of exposure.

The Board denied service connection for prostate cancer as there was no evidence of herbicide exposure during service and the disease did not manifest within one year of separation.

The Veteran's service connection for prostate cancer and cause of death (coronary artery disease) is granted due to exposure to herbicide agents during his service at U-Tapao Royal Thai Air Force Base in Thailand.

The Board has restored the 100 percent initial evaluation for service-connected residuals of prostate cancer, effective from February 1, 2018.

The Veteran's death was not caused by a service-connected disability, and he did not meet the criteria for DIC under 38 U.S.C. § 1318.

The Board has determined that the reduction of the rating for prostate cancer from 100% to 60%, effective November 1, 2016, was proper. The appeal is denied as there is no evidence of a higher disability rating.

The Board has decided that the Veteran's claims for service connection for prostate cancer and diabetes mellitus need further investigation due to incomplete records, particularly regarding his exposure in service. The VA is instructed to obtain all relevant medical records and personnel records from official sources.

The Veteran's claim for service connection for prostate cancer was reopened due to new and material evidence. However, the claim was denied as there is no direct or presumptive evidence linking prostate cancer to his military service, including exposure at Camp Lejeune.

The Board has remanded the case due to an inadequate VA examination and a need for additional evidence.

The Veteran's prostate cancer is granted service connection, while his hyperlipidemia is denied. Service connection for other conditions remains pending.

The Board has remanded the Veteran's claims for hypertension, heart disorder, edema of the lower extremities, prostate disorder, and urinary tract disorder due to inadequate etiological opinions provided by VA examiners. The Veteran must be afforded additional VA examinations to determine the onset and/or etiology of his claimed conditions.

The Board has determined that the Veteran's claim for service connection for prostate cancer was pending at his death and remanded to determine if he had exposure to herbicide agents in Vietnam. The appellant is seeking substitution as the surviving spouse of the Veteran.

The Board has remanded the case due to inadequate medical opinions regarding the relationship between prostate cancer and service-connected prostatitis. The Veteran's claim will be returned for further examination.

The Veteran's prostate cancer is granted service connection as it was related to asbestos exposure during his military service.,Service connection for bladder cancer remains pending due to insufficient evidence regarding the Veteran's in-service exposure.

The Veteran's claims for service connection for various conditions, including prostate cancer and a psychiatric disorder, were denied as there was no evidence of current disabilities or chronic symptoms related to service. The Board found that the Veteran did not have a current diagnosis of PTSD and that prostate cancer and depression are not related to service.

The Veteran was granted service connection for peripheral vestibular disorder and migraines, with a 50% disability rating.,His tinnitus is also now service-connected.

The Veteran's prostate cancer was found to be no longer active, leading to a decrease in his rating from 100% to 40%. The Board granted him a higher rating of 60% for the residuals of his prostate cancer starting November 1, 2018.

The Veteran's prostate cancer is granted on a presumptive basis due to exposure to herbicide agents in Thailand. Service connection for lung cancer, asthma, and COPD are denied.

The Veteran's prostate cancer residuals were rated at 10 percent from December 1, 2015 to January 18, 2021. The Board found that the evidence did not show a worsening of symptoms during this period and denied his claim for an increased rating.